Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia

doi:10.18240/ijo.2016.07.23

Home > Archive>Volume 9, Issue 7, 2016 >1076-1078. DOI:10.18240/ijo.2016.07.23

Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia
DOI:
                        10.18240/ijo.2016.07.23
                    
Author:
                        
                        
                    
Corresponding Author:Christos Chryssafis. An der Klinik 10, Sulzbach 66280, Saar, Germany. retina7@otenet.gr
Affiliation:
Clc Number:
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Reference

Cited by

Get Citation

Christos Chryssafis, Aljoscha Steffen Neubauer, Efstathios Papadopoulos, et al. Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia. Int J Ophthalmol, 2016,9(7):1076-1078

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

Publication History

Received:June 18,2015
Revised:October 29,2015
Adopted:
Online: July 12,2016
Published:

Home

Articles

Journal Info

For Authors

For Reviewers

Publication Policies

News and Events

RSS

Get Citation

Share

Article Metrics

Publication History